ec 27 has been researched along with pituitrin in 2 studies
| Studies (ec 27) | Trials (ec 27) | Recent Studies (post-2010) (ec 27) | Studies (pituitrin) | Trials (pituitrin) | Recent Studies (post-2010) (pituitrin) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 22,137 | 594 | 2,101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauvel, E; Corvol, P; Fournie-Zaluski, MC; Llorens-Cortes, C; Roques, BP; Zini, S | 1 |
| Llorens-Cortes, C | 1 |
2 other study(ies) available for ec 27 and pituitrin
| Article | Year |
|---|---|
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Injections, Intraventricular; Kinetics; Male; Mice; Protease Inhibitors; Saralasin; Substrate Specificity; Sulfhydryl Compounds; Sulfonic Acids; Time Factors; Vasopressins | 1996 |
[Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Brain; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Half-Life; Hypothalamus; Injections, Intraventricular; Male; Mice; Protease Inhibitors; Saralasin; Sulfhydryl Compounds; Sulfonic Acids; Vasopressins | 1998 |